The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Genetic Variation and Neuroimaging Measures in Alzheimer Disease
Open accessAbstract
OBJECTIVE: To investigate whether genome-wide association study (GWAS)-validated and GWAS-promising candidate loci influence magnetic resonance imaging measures and clinical Alzheimer's disease (AD) status. DESIGN: Multicenter case-control study of genetic and neuroimaging data from the Alzheimer's Disease Neuroimaging Initiative. SETTING: Multicenter GWAS. Patients A total of 168 individuals with probable AD, 357 with mild cognitive impairment, and 215 cognitively normal control individuals recruited from more than 50 Alzheimer's Disease Neuroimaging Initiative centers in the United States and Canada. All study participants had APOE and genome-wide genetic data available. MAIN OUTCOME MEASURES: We investigated the influence of GWAS-validated and GWAS-promising novel AD loci on hippocampal volume, amygdala volume, white matter lesion volume, entorhinal cortex thickness, parahippocampal gyrus thickness, and temporal pole cortex thickness. RESULTS: Markers at the APOE locus were associated with all phenotypes except white matter lesion volume (all false discovery rate-corrected P values < .001). Novel and established AD loci identified by prior GWASs showed a significant cumulative score-based effect (false discovery rate P = .04) on all analyzed neuroimaging measures. The GWAS-validated variants at the CR1 and PICALM loci and markers at 2 novel loci (BIN1 and CNTN5) showed association with multiple magnetic resonance imaging characteristics (false discovery rate P < .05). CONCLUSIONS: Loci associated with AD also influence neuroimaging correlates of this disease. Furthermore, neuroimaging analysis identified 2 additional loci of high interest for further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the SNPs of BIN1, such as rs744373 and rs7561528, may contribute to AD susceptibility by impacting brain structure and function [480, 481].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [480]
In the citing paper
“SNPs in and around candidate genes including APOE, BIN1, SORL1, and CR1 have been associated with traits including medial temporal lobe atrophy and cortical thickness [225–228]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,995
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Peter, H., Penzel, T., Peter, J. H., & Peter, J. G. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_302294 · Cited by 2,278
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Reynolds, C. R., & Powel, J. (1988) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/3.4.397 · Cited by 2,123
Purcell, S., Cherny, S. S., & Sham, P. C. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.149 · Cited by 2,057
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364
Buckner, R. L., Head, D. M., Parker, J. B., Fotenos, A. F., Marcus, D. S., Morris, J. C., & Snyder, A. Z. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.018 · Cited by 1,325
Diagnostic and Statistical Manual of Mental Disorders
(2018) · Sage eBooks · doi:10.4135/9781506326139.n198 · Cited by 1,244
Genome-wide association study identifies eight loci associated with blood pressure
Wellcome Trust Case Control Consortium, Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.361 · Cited by 1,215
Myocardial Infarction Genetics Consortium (2009) · Nature Genetics · doi:10.1038/ng.327 · Cited by 1,088
2009 Alzheimer's disease facts and figures
Alzheimer's Association (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.03.001 · Cited by 555
Genetic influences on human brain structure: A review of brain imaging studies in twins
Peper, J. S., Brouwer, R. M., Boomsma, D. I., Kahn, R. S., & Pol, H. E. H. (2007) · Human Brain Mapping · doi:10.1002/hbm.20398 · Cited by 437
Karas, G. B., Burton, E. J., Rombouts, S. A. R. B., van Schijndel, R. A., O'Brien, J. T., Scheltens, P., McKeith, I. G., Williams, D. M., Ballard, C. G., & Barkhof, F. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00041-7 · Cited by 418
Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006501 · Cited by 376
Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures
Henneman, W. J. P., Sluimer, J. D., Barnes, J., van der Flier, W. M., Sluimer, I. C., Fox, N. C., Scheltens, P., Vrenken, H., & Barkhof, F. (2009) · Neurology · doi:10.1212/01.wnl.0000344568.09360.31 · Cited by 350
Butler, M. H., David, C., Ochoa, G.-C., Freyberg, Z., Daniell, L., Grabs, D., Cremona, O., & Camilli, P. D. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1355 · Cited by 256
Genetics of Alzheimer's Disease: A Centennial Review
Ertekin‐Taner, N. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.009 · Cited by 243
Age, Alzheimer disease, and brain structure
Raji, C. A., López, O. L., Kuller, L. H., Carmichael, O. T., & Becker, J. T. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c3f293 · Cited by 230
The BAR Domain Proteins: Molding Membranes in Fission, Fusion, and Phagy
Ren, G., Vajjhala, P. R., Lee, J. S., Winsor, B., & Munn, A. L. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.37-120.2006 · Cited by 220
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease
Guo, X., Wang, Z., Li, K., Li, Z., Qi, Z., Jin, Z. H., Yao, L., & Chen, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.086 · Cited by 164
Structural Analysis of the Human BIN1 Gene
Wechsler-Reya, R., Sakamuro, D., Zhang, J., Duhadaway, J., & Prendergast, G. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31453 · Cited by 142
Desikan, R. S., Cabral, H. J., Fischl, B., Guttmann, C. R. G., Blacker, D., Hyman, B. T., Albert, M. S., & Killiany, R. J. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1397 · Cited by 94
Appel, J., Potter, E. L., Bhatia, N. S., Shen, Q., Zhao, W., Greig, M. T., Raj, A., Barker, W., Potter, H., Schofield, E., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1693 · Cited by 51
Kamei, Y., Takeda, Y., Teramoto, K., Tsutsumi, O., Taketani, Y., & Watanabe, K. (2000) · Genomics · doi:10.1006/geno.2000.6310 · Cited by 37
Potkin, S. G., Guffanti, G., Lakatos, A., Ja, T., Kruggel, F., Jh, F., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · UNICA IRIS Institutional Research Information System (University of Cagliari) · Cited by 34
Neuroimaging to assess safety and efficacy of AD therapies
Hill, D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903381320 · Cited by 26
Cited by
Sorted by citations
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,033
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
the Alzheimer’s Disease Neuroimaging Initiative, E. C., Thompson, P. M., Stein, J. L., Medland, S. E., Hibar, D. P., Vasquez, A. A., Renteria, M. E., Toro, R., Jahanshad, N., Schumann, G., et al. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9269-5 · Cited by 838
Metadata
- Authors
- Biffi, A.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Biffi, Alessandro
- ORCID
- Biffi, Alessandro
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-06-01
- Volume
- 67
- Issue
- 6
- Pages
- 677
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2956757
- OpenAlex
- W2105172870
- Cited by
- 222
- References
- 36
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 14 · 2019: 17 · 2018: 14 · 2017: 9 · 2016: 28 · 2015: 14 · 2014: 19 · 2013: 26 · 2012: 14
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Foundation for the National Institutes of Health (U01AG024904, AG024904)
- Howard Hughes Medical Institute
- Ellison Medical Foundation
- Alzheimer's Association (AG05681, U01 AG024904)
- American Heart Association
- Bristol-Myers Squibb (U01 AG024904, AG024904)
- Eli Lilly and Company (U01 AG024904, AG024904)
- Pfizer (AG024904, U01 AG024904)
- GlaxoSmithKline (P01AG03991)
- Northern California Institute for Research and Education (U01 AG024904)
- Elan (U01 AG024904)
- Eisai (U01 AG024904, AG024904)
- National Institutes of Health (5u01ag024904-10, 6u54rr020278-06, BIRN002, U01-AG024904, AG05681, RR14075, AG024904, NS042861)
- University of California, Los Angeles
- University of California, San Diego
- National Institute on Aging (U01-AG-024904, AG021910, P30AG010129, R01AG021910, R01AG026484, AG 024904, K01AG030514, AG 05681, P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991, AG02238, U19AG010483, U24AG021886)
- National Institute on Drug Abuse (R21DA026104)
- National Institute of Neurological Disorders and Stroke (R01NS042861, R01NS059727, R01NS052585)
- National Institute of Biomedical Imaging and Bioengineering (R01EB001550, R01EB006758, U01 AG024904, AG024904)
- National Center for Research Resources (U54-RR020278, P41-RR-14075, RR 14075, U24RR021382, R01 RR1659401A1, P41RR014075, BIRN002, R01RR016594, U01 AG024904)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genetic loci, genome-wide association study, hippocampal volume, amygdala volume, white matter lesions, cortical thickness, apolipoprotein E, complement receptor 1, PICALM, BIN1, CNTN5, mild cognitive impairment, Alzheimer's Disease Neuroimaging Initiative
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Canada, Cognition Disorders, Female, Genotype, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Nuclear Proteins, Risk Factors, United States, Reproducibility of Results, Cell Adhesion Molecules, Neuronal, Logistic Models, Odds Ratio, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
